Wednesday, January 2, 2019

Pharma Reviews: ANDAs remain pillar of Indian pharma

The US Food and Drug Administration (FDA) has approved a record 741 generic drugs so far in the calendar 2018, with Indian pharma companies ...
Read more: ANDAs remain pillar of Indian pharma